Mumbai, Maharashtra: During an exclusive interview, singer Daboo Malik shared his perspective on creating soulful, romantic ...

High- vs moderate-activity radioactive iodine does not improve recurrence-free survival in intermediate-risk papillary thyroid cancer.

Individuals living with adult growth hormone deficiency are at increased risk of comorbidities and complications.

BANGKOK - Thailand’s digital health landscape is undergoing a massive transformation, and the numbers are telling a clear story: AI model developers are the ...

The vision of a single blood test that could screen for dozens of different cancers has tantalized oncologists for more than ...

Amgen's Tepezza became the first drug approved by the FDA for thyroid eye disease (TED) in 2020, and the company is now looking to extend its role with a new, more patient-friendly formulation. The ...